You are here:
Publication details
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry
| Authors | |
|---|---|
| Year of publication | 2026 |
| Type | Peer-reviewed scientific article |
| Magazine / Source | American Journal of Hematology |
| MU Faculty or unit | |
| Citation | |
| web | https://onlinelibrary.wiley.com/doi/10.1002/ajh.70166 |
| Doi | https://doi.org/10.1002/ajh.70166 |
| Keywords | hematological malignancy; neglected; opportunistic infection; real-world data; respiratory syncytial virus |
| Description | Respiratory syncytial virus (RSV) is a major cause of acute re-spiratory infections and seasonal hospitalisations, particularlyamong immunocompromised adults. In patients with hema-tological malignancies, RSV can cause severe complications,including pneumonia, respiratory failure, and death, especiallyin those with lymphopenia, recent HSCT, or comorbidities .Although antivirals, monoclonal antibodies, and vaccines existfor other high-risk groups, their efficacy in this populationremains uncertain. Screening and diagnostic protocols areinconsistent, treatments are often empiric, and hematologicalpatients are largely excluded from clinical trials. Moreover, com-parative data versus influenza and SARS- CoV-2 are limited, im-peding the development of targeted, evidence-based preventionand management strategies for this vulnerable group. |